MAPT and Alzheimer disease: Among these, 61 proteins were significantly more abundant in the CSF of AD patients, including tau (displayed by the gene name MAPT) in agreement with ELISA results and consistent with the clinical classification of patients (Fig. 2A and supplemental Table S4).